TABLE 1.
Protein | Amino acid variation | Reference for presence in clinical isolates or experimentally evolved mutants | Reference for quantification of resistanceb | PROVEAN valuea |
---|---|---|---|---|
G81C | 24 | - | −8.7 | |
G81D | 23 | - | −6.8 | |
GyrA | T83I | This study, 15, 24 | This study, 15 | −3.7 |
Y86N | 23 | - | −8.7 | |
D87N | This study, 15, 24 | This study, 15, 22 | −4.6 | |
D87G | 23 | This study, 22 | −6.6 | |
Q106L | 23 | - | −6.8 | |
E153K | 21 | - | −3.8 | |
S612L | 24 | - | −5.3 | |
GyrB | S466Y | This study, 15 | 15 | −5.1 |
S466F | This study, 15, 16 | 15 | −5.1 | |
P749S | This study | - | −5.9 | |
NfxB | P22Q | This study | - | −6.7 |
A30V | This study | - | −3.9 | |
A38G | This study | - | −3.8 | |
T39P | 24 | This study, 22 | −5.6 | |
R42C | This study, 76 | - | −7.5 | |
E75G | This study | - | −3.8 | |
R82L | This study, 77 | - | −4.5 | |
H87R | 76 | - | −4.8 | |
ParC | S87L | This study, 24 | This study | −5.9 |
S87W | 15 | 15 | −6.9 | |
ParE | M437I | 15 | - | −2.9 |
P438S | This study, 23 | - | −7.9 | |
S457C | This study, 23 | - | −4.9 | |
V460G | 24 | This study | −6.9 | |
A473V | This study, 78 | - | −2.4 | |
Plasmid mediated protein | CrpP | This study, 29 | - | - |
PROVEAN analysis was carried out as described in reference 24. Variants with PROVEAN values equal to or below −2.5 are likely to be function-altering variants.
The symbol - indicates not tested.